Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1996-11-19
|
pubmed:abstractText |
With advances in molecular biology, the complex inflammatory events that underlie asthma are being unraveled. The players are diverse, involving two populations each of mast cells and helper T cells, eosinophils, bronchial endothelial and epithelial cells, and an array of vasoactive and bronchoactive mediators. The clinical message is already clear: Treat the inflammation early.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
2154-8331
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-9, 124, 126 passim
|
pubmed:dateRevised |
2010-6-18
|
pubmed:meshHeading | |
pubmed:year |
1996
|
pubmed:articleTitle |
Molecular mediators of asthma: current insights.
|
pubmed:affiliation |
University of Southampton, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|